Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High fever occurring 4 to 5 days post-transplant of haploidentical bone marrow or peripheral blood stem cells after reduced-intensity conditioning associated with the use of post-transplant cyclophosphamide as prophylaxis for graft-versus-host disease.

× No keyword cloud information.

17 in total

1. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.

Authors: Shannon R McCurdy; Leo Luznik
Journal: Hematology Am Soc Hematol Educ Program Date: 2019-12-06

2. Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.

Authors: Philip H Imus; Amanda L Blackford; Maria Bettinotti; Leo Luznik; Ephraim J Fuchs; Carol Ann Huff; Douglas E Gladstone; Richard F Ambinder; Ivan M Borrello; Robert J Fuchs; Lode J Swinnen; Nina Wagner-Johnston; Christian B Gocke; Syed Abbas Ali; F Javier Bolaños-Meade; Richard J Jones; Amy E Dezern
Journal: Biol Blood Marrow Transplant Date: 2019-08-05 Impact factor: 5.742

3. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide.

Authors: Naoki Kurita; Tatsuhiro Sakamoto; Takayasu Kato; Manabu Kusakabe; Yasuhisa Yokoyama; Hidekazu Nishikii; Mamiko Sakata-Yanagimoto; Naoshi Obara; Yuichi Hasegawa; Shigeru Chiba
Journal: Ann Hematol Date: 2021-02-12 Impact factor: 3.673

4. Rapid identification of cytokine release syndrome after haploidentical PBSC transplantation and successful therapy with tocilizumab.

Authors: C Cho; M A Perales
Journal: Bone Marrow Transplant Date: 2016-09-26 Impact factor: 5.483

5. Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.

Authors: Shannon R McCurdy; Stephen T Muth; Hua-Ling Tsai; Heather J Symons; Carol Ann Huff; William H Matsui; Ivan Borrello; Douglas E Gladstone; Lode J Swinnen; Kenneth R Cooke; Robert A Brodsky; Javier Bolaños-Meade; Richard F Ambinder; Ravi Varadhan; Leo Luznik; Richard J Jones; Maria P Bettinot; Ephraim J Fuchs
Journal: Biol Blood Marrow Transplant Date: 2018-06-15 Impact factor: 5.742

6. Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide.

Authors: Sarita Rani Jaiswal; Aditi Chakrabarti; Sumita Chatterjee; Sneh Bhargava; Kunal Ray; Suparno Chakrabarti
Journal: Int J Hematol Date: 2015-11-30 Impact factor: 2.490

7. Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for Dedicator-of-Cytokinesis 8 Deficiency Using Post-Transplantation Cyclophosphamide.

Authors: Nirali N Shah; Alexandra F Freeman; Helen Su; Kristen Cole; Mark Parta; Niki M Moutsopoulos; Safa Baris; Elif Karakoc-Aydiner; Thomas E Hughes; Heidi H Kong; Steve M Holland; Dennis D Hickstein
Journal: Biol Blood Marrow Transplant Date: 2017-03-10 Impact factor: 5.742

Review 8. Modern approaches to HLA-haploidentical blood or marrow transplantation.

Authors: Christopher G Kanakry; Ephraim J Fuchs; Leo Luznik
Journal: Nat Rev Clin Oncol Date: 2015-08-25 Impact factor: 66.675

9. Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First Report.

Authors: Mark Parta; Dianne Hilligoss; Corin Kelly; Nana Kwatemaa; Narda Theobald; Harry Malech; Elizabeth M Kang
Journal: J Clin Immunol Date: 2015-10-09 Impact factor: 8.317

Review 10. Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.

Authors: Tara M Robinson; Paul V O'Donnell; Ephraim J Fuchs; Leo Luznik
Journal: Semin Hematol Date: 2016-01-15 Impact factor: 3.851